Menu

Markets

Research

News

Learn
Paper trading
AI Chat
WatchlistsPortfoliosAlerts
Sign in

GALT

Galectin Therapeutics Inc.

Healthcare · USD

Set alert

Price alert · GALT

All alert types
3.32 USD -0.20 -5.68%
As of Oct 30, 2026 Extended hours 3.37 +1.51%
Bid
3.32 × 2
Ask
3.34 × 2
3.27 Day range 3.54
2.08 52-week range 6.51
YTD
-20.19%
1 year
-34.52%
Open
3.52
Prev close
3.52
Mkt cap
334.82M
Vol
174.75K
Avg vol
294.60K
EPS
-0.43
P/E
0.00
Div yield
0.00%
More statistics
Low
3.27
High
3.54
Forward P/E
-0.53
Beta
0.63
Short ratio
42.37
Inst. own
15.77%
Dividend
0.00
Ex-div date
50-d avg
2.51
200-d avg
2.64
1y target
11.00

5D chart

Chart tools
Interval
1m5m15m30m
GALT five-day price chart3.113.263.413.553.70Oct 26Oct 27Oct 28Oct 29Oct 30

Financial health

Altman Z-Score

-55.48 Distress zone

Bankruptcy-risk model: below 1.81 distress, above 2.99 safe.

Piotroski F-Score

2 / 9 Weak

Nine pass/fail tests of profitability, leverage and efficiency.

FMP rating

C2 / 5 overall

  • DCF 1
  • Return on Equity 5
  • Return on Assets 1
  • Debt / Equity 1
  • P/E 1
  • P/B 1

Valuation

P/E -8.7×
FY 2016: -1.3×FY 2017: -7.3×FY 2018: -9.8×FY 2019: -7.3×FY 2020: -5.5×FY 2021: -4.0×FY 2022: -1.7×FY 2023: -2.2×FY 2024: -1.7×FY 2025: -8.7×
FY 2016 5y median -2.2× FY 2025
P/S 0.0×
FY 2016: 0.0×FY 2017: 0.0×FY 2018: 0.0×FY 2019: 0.0×FY 2020: 0.0×FY 2021: 0.0×FY 2022: 0.0×FY 2023: 0.0×FY 2024: 0.0×FY 2025: 0.0×
FY 2016 5y median 0.0× FY 2025
P/B -2.1×
FY 2016: 2.4×FY 2017: 99.4×FY 2018: 19.6×FY 2019: 3.3×FY 2020: 5.3×FY 2021: 46.3×FY 2022: -2.1×FY 2023: -1.7×FY 2024: -0.8×FY 2025: -2.1×
FY 2016 5y median -1.7× FY 2025
P/FCF -11.1×
FY 2016: -1.7×FY 2017: -7.5×FY 2018: -13.3×FY 2019: -13.8×FY 2020: -6.2×FY 2021: -5.0×FY 2022: -2.2×FY 2023: -3.0×FY 2024: -1.9×FY 2025: -11.1×
FY 2016 5y median -3.0× FY 2025
EV/EBITDA -16.3×
FY 2016: -0.6×FY 2017: -7.1×FY 2018: -9.4×FY 2019: -7.7×FY 2020: -4.3×FY 2021: -3.7×FY 2022: -2.3×FY 2023: -3.8×FY 2024: -4.1×FY 2025: -16.3×
FY 2016 5y median -3.8× FY 2025
EV/Sales 0.0×
FY 2016: 0.0×FY 2017: 0.0×FY 2018: 0.0×FY 2019: 0.0×FY 2020: 0.0×FY 2021: 0.0×FY 2022: 0.0×FY 2023: 0.0×FY 2024: 0.0×FY 2025: 0.0×
FY 2016 5y median 0.0× FY 2025
FCF Yield -9.0%
FY 2016: -57.3%FY 2017: -13.4%FY 2018: -7.5%FY 2019: -7.3%FY 2020: -16.1%FY 2021: -20.1%FY 2022: -46.3%FY 2023: -33.0%FY 2024: -52.0%FY 2025: -9.0%
FY 2016 5y median -33.0% FY 2025

Profitability

Gross Margin 0.0%
FY 2016: 0.0%FY 2017: 0.0%FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%FY 2025: 0.0%
FY 2016 5y median 0.0% FY 2025
Operating Margin 0.0%
FY 2016: 0.0%FY 2017: 0.0%FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%FY 2025: 0.0%
FY 2016 5y median 0.0% FY 2025
Net Margin 0.0%
FY 2016: 0.0%FY 2017: 0.0%FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%FY 2025: 0.0%
FY 2016 5y median 0.0% FY 2025
ROE 24.4%
FY 2016: -178.4%FY 2017: -1360.9%FY 2018: -201.5%FY 2019: -29.2%FY 2020: -97.0%FY 2021: -1166.9%FY 2022: 120.4%FY 2023: 68.2%FY 2024: 45.6%FY 2025: 24.4%
FY 2016 5y median 45.6% FY 2025
ROIC -174.3%
FY 2016: -178.8%FY 2017: -1361.9%FY 2018: -197.2%FY 2019: -29.4%FY 2020: -96.7%FY 2021: -92.0%FY 2022: -461.3%FY 2023: -302.9%FY 2024: -1317.0%FY 2025: -174.3%
FY 2016 5y median -302.9% FY 2025
ROA -157.9%
FY 2016: -135.7%FY 2017: -390.2%FY 2018: -154.3%FY 2019: -27.4%FY 2020: -79.3%FY 2021: -73.0%FY 2022: -182.2%FY 2023: -145.6%FY 2024: -268.9%FY 2025: -157.9%
FY 2016 5y median -157.9% FY 2025

Growth (YoY)

Revenue 0.0%
FY 2016: 0.0%FY 2017: 0.0%FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%FY 2025: 0.0%
FY 2016 FY 2025
Operating Income 52.7%
FY 2016: -7.0%FY 2017: 24.4%FY 2018: 16.3%FY 2019: 1.2%FY 2020: -74.5%FY 2021: -28.7%FY 2022: -27.1%FY 2023: 0.7%FY 2024: -11.5%FY 2025: 52.7%
FY 2016 FY 2025
EPS (diluted) 36.8%
FY 2016: 12.0%FY 2017: 37.0%FY 2018: 23.9%FY 2019: -11.4%FY 2020: -5.1%FY 2021: -26.8%FY 2022: -25.0%FY 2023: -13.8%FY 2024: -2.7%FY 2025: 36.8%
FY 2016 FY 2025
Free Cash Flow 42.8%
FY 2016: 3.4%FY 2017: 3.2%FY 2018: 35.9%FY 2019: -6.6%FY 2020: -89.9%FY 2021: -18.0%FY 2022: -27.8%FY 2023: -6.1%FY 2024: -26.7%FY 2025: 42.8%
FY 2016 FY 2025

Financial Health

Current Ratio 2.4×
FY 2016: 4.2×FY 2017: 1.3×FY 2018: 4.2×FY 2019: 17.1×FY 2020: 5.5×FY 2021: 4.6×FY 2022: 1.6×FY 2023: 1.8×FY 2024: 0.5×FY 2025: 2.4×
FY 2016 5y median 1.8× FY 2025
Quick Ratio 2.4×
FY 2016: 4.2×FY 2017: 1.3×FY 2018: 4.2×FY 2019: 17.1×FY 2020: 5.5×FY 2021: 4.6×FY 2022: 1.6×FY 2023: 1.8×FY 2024: 0.5×FY 2025: 2.4×
FY 2016 5y median 1.8× FY 2025
Debt / Equity -1.1×
FY 2016: 0.0×FY 2017: 0.0×FY 2018: 0.0×FY 2019: 0.0×FY 2020: 0.0×FY 2021: 11.1×FY 2022: -1.2×FY 2023: -1.2×FY 2024: -1.0×FY 2025: -1.1×
FY 2016 5y median -1.1× FY 2025
Net Debt / EBITDA -4.9×
FY 2016: 0.7×FY 2017: 0.2×FY 2018: 0.6×FY 2019: 3.6×FY 2020: 1.2×FY 2021: 0.4×FY 2022: -0.6×FY 2023: -1.2×FY 2024: -2.2×FY 2025: -4.9×
FY 2016 5y median -1.2× FY 2025
Interest Coverage -2.7×
FY 2016: 0.0×FY 2017: -1354×FY 2018: -40.5×FY 2019: -154×FY 2020: -269×FY 2021: -61.7×FY 2022: -37.1×FY 2023: -13.6×FY 2024: -7.7×FY 2025: -2.7×
FY 2016 5y median -13.6× FY 2025

Dividends

Dividend Yield 0.0%
FY 2016: 2.6%FY 2017: 1.0%FY 2018: 0.7%FY 2019: 0.3%FY 2020: 0.1%FY 2021: 0.1%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.1%FY 2025: 0.0%
FY 2016 5y median 0.0% FY 2025
Payout Ratio 0.0%
FY 2016: -3.5%FY 2017: -7.6%FY 2018: -6.6%FY 2019: -3.0%FY 2020: -0.6%FY 2021: -0.6%FY 2022: 0.0%FY 2023: 0.0%FY 2024: -0.2%FY 2025: 0.0%
FY 2016 5y median 0.0% FY 2025

Annual · latest fiscal year ends 2025-12-31